Monte Rosa Therapeutics
GLUE
GLUE
53 hedge funds and large institutions have $742M invested in Monte Rosa Therapeutics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 10 reducing their positions, and 11 closing their positions.
Holders
53
Holders Change
-3
Holders Change %
-5.36%
% of All Funds
0.82%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
24
Reduced
10
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$84.7M |
2 |
2
BlackRock
New York
|
$48.1M |
3 |
3
Jennison Associates
New York
|
$10.8M |
4 |
4
TD Asset Management
Toronto,
Ontario, Canada
|
$2.7M |
5 |
E
5
Ergoteles
New York
|
$1.52M |